Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Champions Oncology Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CSBR
Nasdaq
8731
https://championsoncology.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Champions Oncology Inc
Will Champions Oncology (NASDAQ:CSBR) Spend Its Cash Wisely?
- Apr 17th, 2024 7:45 pm
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript
- Mar 19th, 2024 12:28 pm
Champions Oncology Reports Quarterly Revenue of $12.0 Million
- Mar 12th, 2024 8:30 pm
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
- Mar 7th, 2024 1:00 pm
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
- Mar 6th, 2024 9:35 pm
Pleasing Signs As A Number Of Insiders Buy Champions Oncology Stock
- Mar 5th, 2024 11:29 am
Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript
- Dec 14th, 2023 1:22 pm
Champions Oncology Reports Quarterly Revenue of $11.6 Million
- Dec 12th, 2023 9:00 pm
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
- Dec 4th, 2023 9:30 pm
The past three years for Champions Oncology (NASDAQ:CSBR) investors has not been profitable
- Nov 15th, 2023 12:43 pm
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
- Nov 2nd, 2023 12:30 pm
Champions Oncology Announces the Addition of Brady Davis as President
- Oct 17th, 2023 12:30 pm
Favourable Signals For Champions Oncology: Numerous Insiders Acquired Stock
- Sep 27th, 2023 11:07 am
Champions Oncology Independent Director Acquires 14% More Stock
- Sep 27th, 2023 10:05 am
Champions Oncology Reports Quarterly Revenue of $12.6 Million
- Sep 13th, 2023 8:00 pm
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
- Sep 11th, 2023 8:00 pm
Champions Oncology Announces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
- Aug 22nd, 2023 12:30 pm
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
- Aug 1st, 2023 12:45 pm
Champions Oncology Reports Quarterly Revenue of $13.1 Million
- Jul 24th, 2023 8:00 pm
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
- Jul 20th, 2023 8:00 pm
Scroll